Updated on: 25 February 2019

Roles in: Acute Respiratory Infections Group

1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in the broad topic area of the Group/Unit?

a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
No

b) Payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events?
No

c) Fees for organising education?
No

d) Grants and contracts?
No

e) Funds for a member of staff?
Yes - Prof Cheng has been a site investigator for industry-sponsored trials for Janssen, Gilead, Merck, GSK, Covance and Biocryst. Prof Cheng did not receive funding (directly or indirectly) to participate in these trials, but funded was received by his institution to employ study staff.

f) Fees for consulting?
No

g) Royalty or licences payments?
No

2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by or do you or they own a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

3. Do you own stocks or shares in a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

4. Do you hold any patents (planned, issued or pending) for products relevant to the broad topic area of the Group/Unit?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - Prof Cheng is the Chair of the Advisory Committee for Vaccines, which advises the Australian Therapeutic Goods Administration on vaccine regulation and safety issues; and the Australian Technical Group on Immunisation, which advises the Australian Department of Health on national immunisation policy.